Hi-Tech Pharma Enters Oversold Territory - Tale of the Tape

By Zacks.com,  February 23, 2012, 10:39:01 AM EDT

Hi-Tech Pharmacal Co. 's ( HITK ) share price has entered into oversold territory with a stochastic value of 13.278. The Zacks Consensus Estimate on the company's earnings for the year ending April 2012 increased by 21 cents over the past two months to $3.82 per share. Hi-Tech Pharmacal is a Zacks #2 Rank ("Buy") company.


 
HI TECH PHARMA ( HITK ): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: Investing, Investing Ideas, Stocks

Referenced Stocks: HITK



Latest News Video

Take Control Of Your Wealth
Take Control Of Your Wealth         
How to Avoid Getting Caught Pre-Defection
How to Avoid Getting Caught Pre-Def...
WSJ House of the Week: And the Winner Is…
WSJ House of the Week: And the Winn...
How to Invest When Interest Rates Rise
How to Invest When Interest Rates R...


Sign-in
Existing NASDAQ.com member? Log in here.

By signing into the site using any of the third-party services above, you agree to NASDAQ.com's Terms of Use.




Most Active by Volume:

Company Last Sale Change Net / %
PFE $ 29.40 0.24  0.82%
NOK $ 3.86 0.17  4.61%
S $ 7.32 0.10  1.39%
BAC $ 13.27 0.06  0.45%
GE $ 24.33 0.56  2.36%
MU $ 13.76 0.52  3.93%
SIRI $ 3.40 0.06  1.80%
MNKD $ 6.605 0.94  12.40%